Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2018-04-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.1800550115PMID 29674449PMCID PMC5948994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myeloid

  2020cited by this paper
• Human Vγ9/Vδ2 T cells: Innate adaptors of the immune system.

  2015cited by this paper
• STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells

  2015cited by this paper
• HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties

  2014influential reference
• The Yin and Yang of Toll-like receptors in cancer

  2014cited by this paper
• Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.

  2014cited by this paper
• Development and function of dendritic cell subsets.

  2014cited by this paper
• Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.

  2014cited by this paper
• Molecular control of steady-state dendritic cell maturation and immune homeostasis.

  2013cited by this paper
• The response of human dendritic cells to co-ligation of pattern-recognition receptors

  2012cited by this paper
• hTERT-based therapy: a universal anticancer approach (Review).

  2012cited by this paper
• Cancer immunotherapy via dendritic cells

  2012cited by this paper
• The structural bases of direct T‐cell allorecognition: implications for T‐cell‐mediated transplant rejection

  2011cited by this paper
• Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

  2010cited by this paper
• Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

  2010cited by this paper
• Isolation of human blood DC subtypes.

  2010cited by this paper
• DC-SIGN Mediates Cell-Free Infection and Transmission of Human T-Cell Lymphotropic Virus Type 1 by Dendritic Cells

  2009cited by this paper
• Fast generation of dendritic cells.

  2009cited by this paper
• Human dendritic cell line models for DC differentiation and clinical DC vaccination studies

  2008cited by this paper
• Human and murine model cell lines for dendritic cell biology evaluated.

  2008cited by this paper
• Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling

  2008cited by this paper
• Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4+ T cells

  2008cited by this paper
• How a home-grown T cell receptor interacts with a foreign landscape.

  2007cited by this paper
• In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line

  2006cited by this paper
• Phenotypical and functional characterization of clinical-grade dendritic cells.

  2005cited by this paper
• TRAF6 is a critical factor for dendritic cell maturation and development.

  2003cited by this paper
• Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction

  2003cited by this paper
• MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors.

  2002cited by this paper
• Lipopolysaccharide Signals an Endothelial Apoptosis Pathway Through TNF Receptor-Associated Factor 6-Mediated Activation of c-Jun NH2-Terminal Kinase1

  2002cited by this paper
• Phenotypical and Functional Characterization of Clinical Grade Dendritic Cells

  2002cited by this paper
• Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes.

  2002cited by this paper
• Tumor necrosis factor receptor-associated factors (TRAFs)

  2001cited by this paper
• The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells.

  2000cited by this paper
• The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte–derived dendritic cells

  2000cited by this paper
• Brief Definitive Report Dendritic Cell Survival and Maturation Are Regulated by Different Signaling Pathways

  year unknowncited by this paper

• Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity

  2025influential citation
• Advances in Composite Biofilm Biomimetic Nanodrug Delivery Systems for Cancer Treatment

  2024cites this paper
• Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro

  2024cites this paper
• Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients

  2023cites this paper
• Cryobiology and Cryomedicine Techniques’ Boosting in Wartime

  2023cites this paper
• Versatile biomimetic nanomedicine for treating cancer and inflammation disease

  2023cites this paper
• Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy

  2022cites this paper
• Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer

  2022cites this paper
• Immunological and functional aspects of MAGEA3 cancer/testis antigen.

  2021cites this paper
• Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells

  2021cites this paper
• Recent Advances of Cell Membrane‐Coated Nanomaterials for Biomedical Applications

  2020cites this paper
• Clinical implication of cellular vaccine in glioma: current advances and future prospects

  2020cites this paper
• Cell‐Membrane‐Display Nanotechnology

  2020cites this paper
• Understanding Normal and Malignant Human Hematopoiesis Using Next-Generation Humanized Mice.

  2020cites this paper
• The quest for faithful in vitro models of human dendritic cells types.

  2020cites this paper
• Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting

  2020cites this paper
• 40 years of the human T-cell leukemia virus: past, present, and future

  2019cites this paper
• Self‐Assembly of Therapeutic Peptide into Stimuli‐Responsive Clustered Nanohybrids for Cancer‐Targeted Therapy

  2019cites this paper
• Transplantation of neural scaffolds consisting of dermal fibroblast-reprogrammed neurons and 3D silk fibrous materials promotes the repair of spinal cord injury.

  2019cites this paper
• Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells

  2019cites this paper
• Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells

  2019cites this paper